Gabriele Corso
@gcorso.bsky.social
3K followers 100 following 100 posts
PhD student @MIT • Research on Generative Models for Biophysics and Drug Discovery
Posts Media Videos Starter Packs
gcorso.bsky.social
Pretty surreal when out of the blue you see your model up on an ad on highway billboards and airport screens 🤯 (pictures from San Diego Airport and a highway in SF)
gcorso.bsky.social
Boltz v2.2.1 out. A few improvements including support for .pdb templates, better treatment of stereochemistry in guidance potentials, and improved documentation. As always a great thank you to all those in the community who contributed via PR, raising issues or directly reporting issues to us.
gcorso.bsky.social
Sitting at the #AITHYRA symposium hearing about incredible new high-throughput datasets 🤯! If you have developed new data that you think could improve Boltz, e.g. protein small-molecule affinity, protein protein affinity, binding site (eg via proteomics), let's work together! 🤗
gcorso.bsky.social
Have you tried using the --use_potentials flag?
Reposted by Gabriele Corso
chimerax.ucsf.edu
Here's how to predict binding of tens or hundreds of small molecules to protein assemblies using Boltz 2 in ChimeraX.
Accuracy depends on how similar the ligands and binding pockets are to existing experimental structures.
www.rbvi.ucsf.edu/chimerax/dat...
Reposted by Gabriele Corso
Reposted by Gabriele Corso
martinsteinegger.bsky.social
If you use Boltz1/2, BioEmu, Chai1, or other MSA-dependent models, you’re likely using our ColabFold server. Please be considerate! Avoid large submissions across many IPs instead generate the MSA locally. Our server is an old-timer from 2014 and can’t handle that load.
Reposted by Gabriele Corso
chimerax.ucsf.edu
ChimeraX daily builds can predict binding affinity of small molecules using Boltz 2 on your Mac, Windows or Linux computer. www.rbvi.ucsf.edu/chimerax/dat...
Reposted by Gabriele Corso
alexander-ille.bsky.social
Excited to share our work on modeling the human protein interactome in 3D. This currently includes 1,394 interaction structures predicted with Boltz-2. Grateful for the open-access resources making this possible!

Preprint: doi.org/10.1101/2025...
Reposted by Gabriele Corso
gcorso.bsky.social
Nice interview of Phil Sharp on the controversial birth of biotech and recombinant DNA with some great analogies to the current discourse on AI and gene editing!

- YouTube www.youtube.com/watch?v=LLij...
- Spotify spotifycreators-web.app.link/e/NNmzqnTjgUb
- Apple podcasts.apple.com/us/podcast/h...
The Nobel that Sparked Biotech - Prof Phil Sharp
YouTube video by Health Horizons
www.youtube.com
gcorso.bsky.social
We will be hosted by @hannes-stark.bsky.social in his renowned reading group!
gcorso.bsky.social
Thank you everyone for attending the Boltz-2 Boston, San Francisco and Paris events this week! Given the success of the in-person seminars and the many requests, we are organizing a virtual seminar on Tuesday at 12pm ET / 6pm CET! Sign up here: lu.ma/4bpuwbsr
Reposted by Gabriele Corso
sciencex.bsky.social
A new AI model jointly predicts protein structure and binding affinity, enabling rapid, accurate screening of small molecules and accelerating early-stage drug discovery. Boltz-2 is now open source.
Protein-binding affinity model expands role of AI in drug discovery
Understanding how molecules interact is central to biology: from decoding how living organisms function to uncovering disease mechanisms and developing life-saving drugs.
phys.org
Reposted by Gabriele Corso
recursionpharma.bsky.social
Open science, activated.

Since the release of Boltz-2 last Friday – the new open-source protein structure and protein binding affinity model from MIT & Recursion – we’ve been introducing the model to the broader community and the reception has been terrific. 🧵
Reposted by Gabriele Corso
recursionpharma.bsky.social
On June 18 at the Molecular Machine Learning Conference (MoML) at MILA, Gabriele Corso, one of the lead researchers behind Boltz-2, will present more on this latest breakthrough in AI drug discovery alongside researchers from Valence.

👉 Learn more: portal.ml4dd.com #MOML2025
Home | MoML 2025
portal.ml4dd.com
Reposted by Gabriele Corso
allthingsapx.bsky.social
Boltz-2 just dropped: open-source AI that predicts both protein complex folds ✚ binding affinities in one shot 🚀

This is a win for protein AI, but let's not forget MSAs, the bioinformatics backbone many structure models lean on.
Reposted by Gabriele Corso
nboyd.bsky.social
We added Boltz-2 to our protein design package! Under the hood this relies on a JAX translation, which, thanks to @jeremywohlwend.bsky.social and @gcorso.bsky.social ’s clean code, was fairly easy to write. We’ve been getting great results -- and we have yet to explore the most exciting new features
Reposted by Gabriele Corso
openfree.energy
It's exciting to see our software used as a benchmark for cutting-edge AI methods!
gcorso.bsky.social
On the standard FEP+ affinity benchmark, whose targets were held out of training, Boltz-2 achieves an average Pearson of 0.62—comparable to OpenFE, a widely adopted open-source FEP pipeline, while being over 1000x faster!
Reposted by Gabriele Corso
cenmag.bsky.social
A team led by Regina Barzilay, a computer science professor at MIT, has launched Boltz-2, an algorithm that unites protein folding and prediction of small-molecule binding affinity in one package. cen.acs.org/pharmaceutic... #chemsky 🧪
MIT and Recursion partner for AI drug discovery tool
Freely available Boltz-2 algorithm can predict small-molecule binding affinities
cen.acs.org
Reposted by Gabriele Corso
aihealthmit.bsky.social
What a turnout! 🤯 Thank you to the 400+ attendees who came to listen to the first-ever Boltz-2 presentation in-person and for asking great questions! We look forward to seeing how Boltz-2 will empower future research in biomolecular structure prediction! 🧬🔥 #AIsky
Reposted by Gabriele Corso
themarkfdn.bsky.social
Boltz-2 is here—and it’s poised to transform preclinical drug development. We were lucky to get a preview from Regina Barzilay at our 2025 Scientific Symposium, and we’re proud to support her work on the @cancergrand.bsky.social Matchmakers team. www.cancergrandchallenges.org/news/boltz-2...
Boltz-2: democratising the future of drug design
Open source structure prediction with binding affinity
www.cancergrandchallenges.org
Reposted by Gabriele Corso
aihealthmit.bsky.social
'93 Nobel Prize laureate and Jameel Clinic Advisory Board Chair Phil Sharp breaks down why Boltz-2 is so groundbreaking. Join @gcorso.bsky.social + @jeremywohlwend.bsky.social today @ 4pm in Stata Center for their talk on Boltz-2!
🗓️RSVP: jclinic.mit.edu/events/unvei...
🎬: youtu.be/YDrFggLBEQw?...
'93 Nobel Laureate Phillip Sharp on significance of Boltz-2 and affinity binding
YouTube video by MIT Jameel Clinic - AI & Health
youtu.be
Reposted by Gabriele Corso
gebauer.bsky.social
This sounds really interesting! Eager to test it with some structures we have lying around. 👍
gcorso.bsky.social
Excited to unveil Boltz-2, our new model capable not only of predicting structures but also binding affinities! Boltz-2 is the first AI model to approach the performance of FEP simulations while being more than 1000x faster! All open-sourced under MIT license! A thread… 🤗🚀